Posted on 8/22/18
Kaleido Biosciences Appoints Alison Lawton as CEO
Kaleido Biosciences, a clinical-stage healthcare company leading the development of novel chemistries that drive functions
Posted on 8/17/18
Dicerna Appoints J. Kevin Buchi and Cynthia Smith to Board
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics
Posted on 8/16/18
Perkins School for the Blind Adds Four to Board of Trustees
Perkins School for the Blind, the first school for the blind in the U.S. and the international leader in blindness education has added long-time Members
Posted on 8/16/18
Aeromics, Inc. Appoints Pharmaceutical and Biotech Veterans Mark Day, Ph.D. and Thomas Zindrick, J.D. to Its Board of Directors
Aeromics, Inc., a privately-held, clinical-stage pharmaceutical company focused on controlling cerebral edema, or brain swelling, for people affected by disabling
Posted on 8/16/18
Cardurion Pharmaceuticals Appoints Jeb Keiper to Its Board of Directors
Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of cardiovascular diseases
Posted on 8/16/18
Spring Bank Pharmaceuticals Appoints Scott Smith to its Board of Directors
Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics
Posted on 8/15/18
Terex Board Elects John L. Garrison as Chairman
Terex Corporation (NYSE:TEX) announced that John L. Garrison, Terex’s President and Chief Executive, will also assume the position of Chairman
Posted on 8/15/18
resTORbio Appoints Jeffrey Chodakewitz, M.D., to its Board of Directors
resTORbio, Inc. (Nasdaq:TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development
Posted on 8/15/18
Vantis CEO Peter Tedone Announces Retirement
Longtime CEO of Vantis Life Insurance Company Peter Tedone has announced that he will retire at the end of the year from the company where he . . .
Posted on 8/15/18
Elaine R. Gillim, CFA Joins Boston Trust
Boston Trust & Investment Management Company is pleased to announce that Elaine R. Gillim, CFA has joined the firm as a Senior Wealth Advisor. Elaine will . . .
Posted on 8/15/18
Centrexion Therapeutics Appoints Dan Mendelson to its Board of Directors
Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-addictive therapeutics for the treatment of chronic pain
Posted on 8/15/18
SciFluor Announces Appointment of Robert Dempsey to Board of Directors
CAMBRIDGE, Mass.--(BUSINESS WIRE)--SciFluor Life Sciences, Inc. today announced that Robert Dempsey, MBA, has joined the Board of Directors. Robert will bring his extensive knowledge of the . . .
Posted on 8/15/18
Lumicell Expands Board with Addition of Michael Ruettgers
Lumicell, Inc., an innovation leader in molecular imaging within healthcare focused in cancer, perfusion, wound care and infection
Posted on 8/15/18
Karuna Appoints Steven Paul, M.D., as CEO
Karuna Pharmaceuticals, Inc., focused on targeting muscarinic cholinergic receptors for the treatment of neuropsychiatric disorders marked by psychosis and cognitive impairment,
Posted on 8/14/18
MKM Partners CEO Richard Castellano Retires
MKM Partners today announced that Richard Castellano has decided to retire after nearly 10 years of leadership as the firm's CEO.
Posted on 8/14/18
Spero Appoints John C. Pottage, Jr., MD to its Board of Directors
Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing
Posted on 8/14/18
Sigilon Therapeutics Appoints Rogerio Vivaldi, M.D., as CEO
Sigilon Therapeutics, a biopharmaceutical company that discovers and develops immune-privileged living therapeutics, today announced that Rogerio Vivaldi, M.D.
Posted on 8/14/18
Spero Announces Appointment of John C. Pottage, Jr., MD to its Board of Directors
Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments
Posted on 8/12/18
Marcel Boehkoorn Joins Carlyle Group-backed Mazarine Energy’s Board
Dutch private equity firm Ramphastos Investments today announces the appointment of its founder and CEO, Marcel Boekhoorn, to the Board of Directors of Mazarine Energy following . . .
Posted on 8/9/18
Precipio Appoints Kathleen LaPorte to Board
Specialty cancer diagnostics company Precipio, Inc.(NASDAQ: PRPO), today announced the appointment of veteran life sciences venture capitalist
Posted on 8/8/18
Rudolph Technologies Appoints David B. Miller as Chairman of the Board
Rudolph Technologies, Inc. (NYSE: RTEC) announces the appointment of David B. Miller to the role of Chairman of the Board of Directors with an effective date . . .
Posted on 8/8/18
Steven Mason Assumes Role of CEO at ChartWise Medical Systems
ChartWise Medical Systems, Inc., an award-winning industry leader in web-based, computer-assisted Clinical Documentation Improvement (CDI) solutions
Posted on 8/8/18
Michael Apkon, MD, PhD Named CEO Of Tufts Medical Center
An acclaimed health care administrator, physician and researcher who has held leadership positions at three of the top academic medical centers
Posted on 8/8/18
Riverside Partners-backed Calero Software Appoints Joe Pajer as CEO
Calero Software, a leading global provider of Communications and Cloud Lifecycle Management (CLM) software and managed services, including Telecom Expense Management (TEM), Managed Mobility Services (MMS) . . .
Posted on 8/7/18
The Workforce Institute at Kronos Appoints Alexandra Levit to Americas Board of Advisors
The Workforce Institute at Kronos Incorporated, a think tank dedicated to providing research and education on critical workplace
Boston
